Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
Annie A Wu, Katherine M Bever, Won Jin Ho, et al.
Cancer Immunology Research
|
January 12, 2026
A randomized phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and mKRAS-specific T cells into PDAC
Katherine M Bever, Amanda L Huff, Ludmila Danilova, et al.
Cancer Immunology Research
|
January 12, 2026
Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses
Dimitri N Sidiropoulos, Zhehao Zhang, Jennifer N Durham, et al.
Oncotarget
|
June 12, 2020
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma
Katherine M Bever, Erkut H Borazanci, Elizabeth A Thompson, et al.
Oncoimmunology
|
August 15, 2025
A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages
Katherine M Bever, Sarah M Shin, Jennifer N Durham, et al.
JCI Insight
|
August 6, 2024
Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma
Nicole E Gross, Zhehao Zhang, Jacob T Mitchell, et al.
Nature Communications
|
June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial
Hejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer
Eric S Christenson, Won Jin Ho, Daniel Shu, et al.
Cancer Discovery
|
July 16, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts
S Daniel Haldar, Amanda L Huff, Hejia Henry Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2020
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma
Lei Zheng, Ding Ding, Barish H Edil, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
Annie A Wu, Katherine M Bever, Won Jin Ho, et al.
Cancer Immunology Research
|
January 12, 2026
A randomized phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and mKRAS-specific T cells into PDAC
Katherine M Bever, Amanda L Huff, Ludmila Danilova, et al.
Cancer Immunology Research
|
January 12, 2026
Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses
Dimitri N Sidiropoulos, Zhehao Zhang, Jennifer N Durham, et al.
Oncotarget
|
June 12, 2020
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma
Katherine M Bever, Erkut H Borazanci, Elizabeth A Thompson, et al.
Oncoimmunology
|
August 15, 2025
A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages
Katherine M Bever, Sarah M Shin, Jennifer N Durham, et al.
JCI Insight
|
August 6, 2024
Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma
Nicole E Gross, Zhehao Zhang, Jacob T Mitchell, et al.
Nature Communications
|
June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial
Hejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer
Eric S Christenson, Won Jin Ho, Daniel Shu, et al.
Cancer Discovery
|
July 16, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts
S Daniel Haldar, Amanda L Huff, Hejia Henry Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2020
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma
Lei Zheng, Ding Ding, Barish H Edil, et al.
Page
of 3